Chronopin: upcoming release dates, events and other important dates

Amgen's phase 3 trial of Maridebart Cafraglutide in obesity reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 3,200 participants. The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with obesity or overweight. Trial 20250197 is an extension of trial 20210181 (NCT06858839).

Docking two Starships is the step that makes orbital propellant transfer — and with it Artemis and Mars — possible. On 20 September 2026 Kalshi gave it a 69% chance before 2028, while Polymarket’s dated ladder put only 3.2% on it happening by the end of 2026 against 51.5% by the end of 2027.

The day by which Hershey has committed to stop making US products with FD&C certified colors, moving candies like Twizzlers and Jolly Rancher to colors from spirulina, carrots, radishes and beets.

On 27 October 2026 Kalshi put an official Perplexity IPO confirmation at 15% before Jan 1, 2028, rising to 58% before Jan 1, 2029. The largest step in the ladder runs from Jan 1, 2028 to Jul 1, 2028 (15% to 38%), so that window is the market's most likely stretch; it is a bet on timing, not a listing date.

S1101 is a 200 MW battery storage interconnection request in St. Francis, AR. The grid operator lists its queue status as Active. The requested in-service date is 2028-01-20; this is a planning date.

Greatest eclipse falls at 15:07:46 UT on 2028-01-26, where the annular phase lasts 10 minutes 27 seconds on a path 323.0 km wide; the longest annularity anywhere on the track is 10m30.6s. The path of annularity crosses Ecuador, Peru, Brazil, Suriname, Spain and Portugal, and a partial eclipse is visible from eastern North America, C. & South America, western Europe and northwestern Africa.

Construction is underway on 112 affordable apartments: 56 for adults aged 55+ and 56 for families, at 30%–60% AMI. Eighteen senior apartments have project-based vouchers. Property information reviewed October 10, 2026.

Urban Grid development of the Spring Valley Clean Solar Center Phase 2 in Colbert County, Alabama. Supplying 200 MWac of utility-scale solar generation, the facility interfaces with the Tennessee Valley Authority (TVA) bulk transmission system to accelerate decarbonization across northern Alabama.

The 58MW Parowan PARB battery is planned with approvals not initiated. The operating or proposed solar units do not complete this storage component.

The NFL championship game for the 2027 season is played at Mercedes-Benz Stadium in Atlanta, the city's fourth Super Bowl and the second at this venue after Super Bowl LIII in 2019. CBS has the national broadcast.

Novo Nordisk's phase 3 trial of Cagrisema in obesity reaches primary completion, the point at which the last participant's primary outcome is measured. The trial enrolled 2,500 participants. This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight. The purpose of the study is to find out how safe and effective CagriSema is for body weight loss in these participants. Participants will receive either CagriSema or semaglutide, and which treatment participants receive is decided by chance. CagriSema is a new study medicine being tested, while semaglutide is a medicine that doctors can already prescribe.

Separate construction cost, IT power, floor area and an opening date for this building or phase have not been verified. Published campus figures do not establish independent component figures.

EIA’s September 2026 inventory identifies Hawkeye Solar II plant 70258 at 250 MW with March 2028 planned operation and regulatory approvals pending. It is separate from the 200 MW Hawkeye Solar entry within Ranger’s broader Clinton County development.